143 related articles for article (PubMed ID: 21600313)
1. Refractory disease in systemic lupus erythematosus.
Campar A; Farinha F; Vasconcelos C
Autoimmun Rev; 2011 Sep; 10(11):685-92. PubMed ID: 21600313
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of end-points in clinical trials.
Bertsias G; Gordon C; Boumpas DT
Lupus; 2008 May; 17(5):437-42. PubMed ID: 18490423
[TBL] [Abstract][Full Text] [Related]
3. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment.
Luijten KM; Tekstra J; Bijlsma JW; Bijl M
Autoimmun Rev; 2012 Mar; 11(5):326-9. PubMed ID: 21958603
[TBL] [Abstract][Full Text] [Related]
4. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
5. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
6. The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials.
Abrahamowicz M; Fortin PR; du Berger R; Nayak V; Neville C; Liang MH
J Rheumatol; 1998 Feb; 25(2):277-84. PubMed ID: 9489819
[TBL] [Abstract][Full Text] [Related]
7. Cytokines and their receptors as biomarkers of systemic lupus erythematosus.
Suh CH; Kim HA
Expert Rev Mol Diagn; 2008 Mar; 8(2):189-98. PubMed ID: 18366305
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Terrier B; Amoura Z; Ravaud P; Hachulla E; Jouenne R; Combe B; Bonnet C; Cacoub P; Cantagrel A; de Bandt M; Fain O; Fautrel B; Gaudin P; Godeau B; Harlé JR; Hot A; Kahn JE; Lambotte O; Larroche C; Léone J; Meyer O; Pallot-Prades B; Pertuiset E; Quartier P; Schaerverbeke T; Sibilia J; Somogyi A; Soubrier M; Vignon E; Bader-Meunier B; Mariette X; Gottenberg JE;
Arthritis Rheum; 2010 Aug; 62(8):2458-66. PubMed ID: 20506527
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic modalities in systemic lupus erythematosus.
Tyagi NK; Lahita RG
Saudi Med J; 2013 Sep; 34(9):887-95. PubMed ID: 24042998
[TBL] [Abstract][Full Text] [Related]
10. How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice?
Haq I; Isenberg DA
Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):181-94. PubMed ID: 12041948
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for systemic lupus erythematosus.
Ahearn JM; Liu CC; Kao AH; Manzi S
Transl Res; 2012 Apr; 159(4):326-42. PubMed ID: 22424435
[TBL] [Abstract][Full Text] [Related]
12. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN
J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
[TBL] [Abstract][Full Text] [Related]
13. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus.
Manson JJ; Rahman A
Orphanet J Rare Dis; 2006 Mar; 1():6. PubMed ID: 16722594
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
Lee HJ; Sinha AA
Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
[TBL] [Abstract][Full Text] [Related]
16. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set.
Ruperto N; Ravelli A; Cuttica R; Espada G; Ozen S; Porras O; Sztajnbok F; Falcini F; Kasapcopur O; Venning H; Bica B; Merino R; Coto C; Ros J; Susic G; Gamir ML; Minden K; See Y; Uziel Y; Mukamel M; Riley P; Zulian F; Olivieri AN; Cimaz R; Girschick H; Rumba I; Cavuto S; Pistorio A; Lovell DJ; Martini A; ;
Arthritis Rheum; 2005 Sep; 52(9):2854-64. PubMed ID: 16142708
[TBL] [Abstract][Full Text] [Related]
17. Caring for the adolescent with systemic lupus erythematosus.
Tucker LB
Adolesc Med; 1998 Feb; 9(1):59-67, vi. PubMed ID: 10961252
[TBL] [Abstract][Full Text] [Related]
18. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.
Arthritis Rheum; 1999 Sep; 42(9):1785-96. PubMed ID: 10513791
[TBL] [Abstract][Full Text] [Related]
20. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
Ignat GP; Rat AC; Sychra JJ; Vo J; Varga J; Teodorescu M
J Rheumatol; 2003 Aug; 30(8):1761-9. PubMed ID: 12913932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
